Shandong Bona Biotechnology Group Co., Ltd.

Shandong Bona Biotechnology Group Co., Ltd. located in Jinan High-tech Industrial Park, the production base is located in Zichuan Development Zone Industrial Park, Zibo City. It is a professional manufacturer and operation of membrane filtration separation equipment, organic membrane, ceramic membrane, separation and purification filler. And high-tech enterprises related to chromatographic separation and purification related technology services, products are mainly used in pharmaceutical, biotechnology, food, environmental, petrochemical, metallurgical and other fields.

The company's two membrane filtration production companies, Shandong Woda Film Technology Co., Ltd., Shandong Jiade Jingtong Membrane Technology Co., Ltd.

PRODUCTS

PRODUCTS

High pressure flat membrane experimental equipment (TYLG-19)

Four-stage membrane separation test machine (backwashable)

High pressure flat membrane equipment

Organic membrane separation test machine (BONA-GM-18-7)

Organic membrane filtration experimental equipment (BONA-GM-M18)

Reverse osmosis membrane small experimental machine

Ceramic membrane small experimental machine

Organic membrane separation test machine (BONA-GM-18)

TECHNOLOGY

TECHNOLOGY

  • 2019-08-21
    Rapamycin (RAPA, trade name Sirolimus) is a novel macrolide immunosuppressant with high immunosuppressive effects. From the clinical application point of view, rapamycin has a good anti-rejection effect
  • 2019-08-27
    Antibiotics are mainly used to treat various bacterial infections or pathogenic microbial infections, and generally do not cause serious side effects to their hosts. Antibiotics are generally divided into five categories:
  • 2019-08-27
    The bone soup/osteogen is rich in protein components (bone peptide after enzymatic hydrolysis), and can be used as a food additive after being concentrated by filtration. It has been widely used in food and health care products.
  • 2019-09-24
    Paclitaxel (trade name Taxo1) is a unique anti-tumor natural medicine in the genus Taxus. It was first isolated in 1971 by American chemists Wani and Wallt et al. and was officially approved by the US FDA in 1992. New anti-ovarian cancer drugs.

NEWS CENTER

NEWS CENTER

PARTNER

PARTNER

More>>